SF-36 health survey scores in pirfenidone trial. This figure shows the results of the Medical Outcomes Study SF-36 Health Survey Questionnaire at baseline, 6 months, and 12 months during the Safety and Tolerability of Pirfenidone for Bronchiolitis Obliterans Syndrome trial. The SF-36 survery includes 36 items that assess quality of life across 8 areas: general health perception, physical health problems, role limitations due to physical or emotional problems, emotional well-being, energy/fatigue, pain, and social functioning. Scores range from 0 to 100, with higher scores indicating better health. An increase of more than 5 points is considered a MCID, denoted by #. The data presented are the mean SF-36 percentage scores and the standard error of the mean, analyzed using a paired t test. Statistically significant differences (P < .05) are indicated by ∗∗.
Figure 5.

SF-36 health survey scores in pirfenidone trial. This figure shows the results of the Medical Outcomes Study SF-36 Health Survey Questionnaire at baseline, 6 months, and 12 months during the Safety and Tolerability of Pirfenidone for Bronchiolitis Obliterans Syndrome trial. The SF-36 survery includes 36 items that assess quality of life across 8 areas: general health perception, physical health problems, role limitations due to physical or emotional problems, emotional well-being, energy/fatigue, pain, and social functioning. Scores range from 0 to 100, with higher scores indicating better health. An increase of more than 5 points is considered a MCID, denoted by #. The data presented are the mean SF-36 percentage scores and the standard error of the mean, analyzed using a paired t test. Statistically significant differences (P < .05) are indicated by ∗∗.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal